Navigation Links
Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy

e ADAS-cog difference reached statistical significance (observed case analysis; p=0.006). Dimebon's benefit over placebo on the other two endpoints (the MMSE and the NPI) at six months was maintained at one year.

Jeffrey Cummings, MD, the Augustus Rose Professor of Neurology at the University of California, Los Angeles, and Director of the UCLA Alzheimer's Disease Center stated: "I consider these efficacy data to be noteworthy because they show an overall treatment benefit that is consistent, robust and larger at twelve months than at six. To my knowledge, this is the first randomized, double-blind, placebo-controlled study in which statistically significant benefit was achieved on endpoints measuring each of the four most clinically relevant aspects of mild-to-moderate Alzheimer's disease after a full year of therapy. Given these data and the fact that Dimebon was well tolerated in this study, I consider Dimebon one of the most promising Alzheimer's disease compounds in development."

"The natural history of untreated Alzheimer's disease includes decline in thinking abilities, social behavior and function," observed Rachelle Doody, MD, PhD, the Effie Marie Cain Chair in Alzheimer's Disease Research at the Alzheimer's Disease and Memory Disorders Center, in Houston, and principal investigator of this study. "By contrast, after a full year of therapy Dimebon-treated patients did not decline in any of these areas. These data demonstrate that, as a group, Dimebon-treated patients stabilized for a full year, whereas placebo-treated patients declined at the expected rate."

Dimebon-treated patients experienced significantly fewer serious adverse events than placebo-treated patients (3.4 percent vs. 11.7 percent, respectively; p=0.03) and dropped out of the study at a rate (31.5 percent) consistent with the dropout rate in the placebo group (37.2 percent). The most frequently reported adverse events associated with treatment were dry mouth (18.0 percent
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
2. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
3. Medivation Announces First U.S. Presentation of Data From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Medivation Announces Presentation of Full Top-Line Data From Dimebon Six-Month Trial at Major International Alzheimers Disease Conference
5. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
6. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
7. ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
8. EPIX Pharmaceuticals Announces Statistically Significant Results in Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug Candidate
9. Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of Telcyta as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer
10. Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease
11. Repros Proellex Shows Statistically Significant Improvement in Primary Endpoint in Phase 2 Trial in the Treatment of Uterine Fibroids
Post Your Comments:
(Date:5/17/2013)... YORK , May 17, 2013 /PRNewswire-iReach/ -- United ... Advanced Cardiac Life Support (ACLS), Pediatric Advanced Life Support ... free PALS, BLS and ACLS online course ... manuals, people simply need to build an account with ... materials for these programs, United Medical Education is setting ...
(Date:5/17/2013)... PONCE , Puerto Rico , May ... southern, central and western Puerto Rico , ... , PR) Center has improved its radiation therapy capabilities with ... in Puerto Rico . Versa HD offers ... wide range of tumors throughout the body, while also enabling ...
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
Breaking Medicine Technology:ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
... Sept. 12 Alfacell Corporation,(Nasdaq: ACEL ) ... events,(patient deaths) have occurred in the Phase IIIb ... treatment of patients with unresectable,malignant mesothelioma. The number ... that total events in the study had reached ...
... in the Sept. 12 Issue of the Journal of the American Medical ... ... treat type 2,diabetes has been found to reduce the risk of death, heart ... diabetes, according to a Cleveland Clinic study. The study published in the ...
Cached Medicine Technology:Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 3Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure 2Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure 3
(Date:5/18/2013)... 2013 The topics that will be covered ... scrum roles, scrum meetings, scrum artifacts, and scrum simulation (optional). ... attending them. , These trainings are suitable for business analysts, ... for those who will be a part of the Scrum ... to explore Agile and Scrum, but are unsure of what ...
(Date:5/18/2013)... the the Stevens Johnson Syndrome Foundation, Stevens Johnson Syndrome (SJS), ... reaction usually to medicine (i). The first signs of ... blistering and large areas of dead skin. Some severe ... any time and seriously affect both children and adults. ... after he received kidney medicine which caused SJS (ii). ...
(Date:5/17/2013)... 18, 2013. Chronic trauma can inflict lasting damage to ... studies of people with post-traumatic stress disorder, or PTSD, ... in response to stressful tasks, such as recalling a ... threatening face. Now, researchers at NYU School of Medicine ... the brains of combat veterans with PTSD in the ...
(Date:5/17/2013)... Stryker hip lawsuit claims filed ... ABG II Modular-Neck Hip Stem recall continue to move forward ... According to court documents, a Case Management Conference was held ... which time the Court, among other things, set deadlines by ... submit Fact Sheets to Defendant and Liaison Counsel. The ...
(Date:5/17/2013)... Cleveland, OH (PRWEB) May 17, 2013 ... nosings are an eye-catching, resilient, slip-resistant renovation ... surface. Designed for new construction or staircase renovation ... and durability while providing a look to compliment ... industrial applications, but attractive enough for home stairs ...
Breaking Medicine News(10 mins):Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Reports on Recent Case Management Conference in New Jersey Stryker Hip Recall Litigation 3Health News:New Bold Step Renovation Stair Treads and Nosings from Martinson-Nicholls Add Slip Resistance to Stairs 2
... , PARSIPPANY, N.J., July 15 ... continue to harbor illness-causing bacteria that can threaten families, according ... Council, sponsored by LYSOL((R)) brand products. Investigators swabbing for ... that, despite American home owners claiming to clean their kitchen ...
... deals Governor,s wage cuts for home care workers one more legal ... July 14 California home care recipients, care providers and their ... prevent the Schwarzenegger Administration from cutting In-Home Supportive Services (IHSS) wages. ... 9(th) Circuit Court of Appeals denied an emergency stay request by ...
... , WASHINGTON, July 14 Speaker ... Chairman George Miller, Chairman John Dingell and other senior House Democrats held ... today by the Tri-Committees on health care reform. , ... and closing statement. A transcript of the entire press conference will be ...
... , The Safe and Sound(R) Safety Management ... emergency responders better serve the autism community , ... MedicAlert Foundation International, the leader in emergency response medical information services, ... peace of mind through a new program, Medic Alert + Safe ...
... eating healthy, moderate activity are protective , TUESDAY, July ... that your genes don,t predispose you to dementia. , ... age, according to four new studies that were presented ... Vienna. , The findings echo other research suggesting that ...
... , MIAMI and SAN DIEGO, July 14 ... platform technology for the generation of fully human monoclonal antibodies, ... company with no active operations, have signed a merger agreement ... subsidiary of QuikByte. After the merger is completed, QuikByte ...
Cached Medicine News:Health News:American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens 2Health News:American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens 3Health News:American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens 4Health News:Federal Appeals Court Protects California Home Care Pay 2Health News:Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 2Health News:Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 3Health News:MedicAlert Foundation and Autism Society Launch New Program to Safeguard Individuals and Families Living With Autism 2Health News:MedicAlert Foundation and Autism Society Launch New Program to Safeguard Individuals and Families Living With Autism 3Health News:Healthy Diet, Exercise Keeps Mind Sharp As You Age 2Health News:Healthy Diet, Exercise Keeps Mind Sharp As You Age 3Health News:QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement 2Health News:QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement 3
The Auto Suture™ ExtraHand™ balloon retractor is designed to be used during open surgery, gasless endoscopy, as well as endoscopy with gas insufflation....
Ethicon Endo-Surgery provides disposable handheld instruments that provide reliable, precise performance every time. Our handheld instruments come in 5mm and 10mm sizes....
... Auto Suture™ ENDO RETRACT™ ... (3) atraumatic fingers, has ... of gynecologic, general, urologic, ... for temporary retraction of ...
... RETRACT™ 12 mm instrument has application in ... and other endoscopic procedures for retracting internal ... , ,The ENDO PADDLE RETRACT™ instrument ... distal end of the instrument and is ...
Medicine Products: